The Division of Surgical Oncology offers a state-of-the-art approach to cancer therapy that is centered around multi-disciplinary tumor boards and integrated practice unit clinics. We also prioritize clinical / translational research and applied basic laboratory investigations related to the etiology, diagnosis, and treatment of malignant solid tumors. Physician investigators within the division have special interest in pancreatic, breast, colon, and gastric cancers, as well as sarcoma, melanoma, , and pseudomyxoma peritonei.
The program is based at the Ronald Reagan UCLA Medical Center for inpatient care and the 200 Medical Plaza for outpatient care. Additional locations of service include the UCLA Health - Santa Monica Medical Center and Wadsworth Veterans Administration Medical Centers. Members of the Division of Surgical Oncology have developed pioneering programs that have significantly improved the care of patients with solid tumors through clinical / translational research and innovative surgical approaches.
The primary goal of the Surgical Oncology program is to provide quality state of the art care for its patients. This includes surgical oncology consultation with the staff of the Ronald Reagan UCLA Medical Center and its affiliated hospitals, and multidisciplinary treatment planning in the context of disease specific programs.
We have a high-volume pancreatic cancer and diseases program with outstanding outcomes. We treat patients with pancreatic cancer (adenocarcinoma), pancreatic neuroendocrine tumors, pancreatic cysts, acute pancreatitis, chronic pancreatitis, and periampullary and other bile duct tumors. Our clinical program includes a weekly multi-disciplinary tumor board and clinic where treatment plans are developed by all pertinent experts and patients can consult numerous physicians in one location during the same visit. We have a nurse practitioner and are navigators that minimize the burden on our patients and ensure care is delivered smoothly. We also have many clinical trials for patients to consider. Learn more >
Telephone
310-206-6889 Information and referral
Fax Number
310-825-9565
The UCLA Sarcoma Program provides innovative multidisciplinary treatment for adults and children with sarcoma at any stage of the disease. UCLA is one of the three busiest sarcoma centers in the nation. On an annual basis we evaluate over 1000 patients with sarcoma, over 500 of which undergo surgery at UCLA. At UCLA, a patient’s plan of care is decided by our weekly sarcoma tumor board involving physicians specializing in sarcoma from surgical oncology, orthopedic oncology, gynecologic oncology, medical oncology, radiation oncology, pediatric oncology, pathology and radiology. This group of 15-20 physicians formulate and coordinate optimal treatment strategies for individual patients. Learn more >
Telephone
310-825-7086 Information and referral
Fax Number
310-825-7575
The Revlon/UCLA Breast Center is located on the Westwood campus and housed in the Division of Surgical Oncology. It offers multi-disciplinary care to patients with all breast diseases. Learn more >
Telephone
310-825-2144 Information and referral
The UCLA Melanoma Program provides innovative multi-modality treatment for patients with melanoma at any stage of the disease. Treatment options include lymphatic mapping, biological therapy, and gene therapy. Learn more >
Telephone Number
310-825-2644 Physician referrals
310-825-7086 Self Referrals
Fax Number
310-825-7575
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is a specialized treatment for certain abdominal tumors. The purpose of HIPEC treatment is to kill microscopic cancer cells invisible to the human eye and reduce cancer recurrence. Learn more >
Telephone
310-206-6909 Information and referral
Fax Number
310-825-7575
Physicians
Chief
Timothy Donahue, MD
Physicians
Helena Chang, MD
James Economou, MD, PhD
Fredrick Christian Eilber, MD
James Tomlinson, MD, PhD
Jonathan King, MD
Mark Girgis, MD
Research Faculty
Begonya Comin-Anduix, PhD
Tracy Daniels
Romaine Saxton
Manuel Penichet, MD, PhD
Faculty Joint Appointment
Alistair Cochran, MD
Antoni Ribas, MD
